Asthma Clinical Trial
Official title:
FASTA: Flexibility and Strength Training in Asthma
The aim of the study is proof of concept and to establish the feasibility of performing a study of resistive flexibility and strength training (RFST) in patients with asthma, with the future goal of designing a larger randomized trial to test the hypothesis that RFST leads to greater improvement in asthma symptoms, pulmonary function tests, range of motion and connective tissue mobility compared with a control conventional physical therapy intervention.
The treatment of symptomatic asthma currently focuses on the use of medications - inhaled or
systemic - that have the principal goals of relieving airway pathology, namely airway
narrowing, inflammation, mucus metaplasia and hyper-reactivity. There are no therapies
directed at the chest wall or its connective tissue structural units, including connective
tissue matrix, bone health and chest wall musculature. Resistive flexibility and strength
training (RFST) is a new physical therapy technique that has successfully addressed
abnormalities in the upper and lower extremities and back. In this application, we propose to
use internal funding for a pilot project to explore the potential holistic benefits of RFST
directed to the chest wall in symptomatic asthmatics as well as the potential mechanical
basis of its therapeutic benefits if observed.
In RFST, the practitioner extends or flexes a joint, while the patient actively resists the
motion applied by the practitioner. In other words, the patient performs an eccentric
contraction of extensor muscles if the joint is flexed, or of flexor muscles if the joint is
extended. The technique is based on the following theoretical principles:
- Opposing muscle pairs (i.e. ipsilateral flexor/extensor) can become dysfunctional when
connective tissue within one of the muscles (either the flexor or the extensor) becomes
chronically shortened—thought to be due to long-standing exaggerated centrally driven
tonic muscle activity either following an injury or due to posture habit. When this
happens, connective tissue within the opposing muscle will become chronically lengthened
due to shortening of the paired muscle.
- The connective tissue can become inelastic and restrictive resulting in the muscles
being held in a chronically short or lengthened position. These positions can change.
- In the trunk, imbalances can occur between flexor/extensor groups (e.g.
psoas/multifidus) and also between right/left muscle pairs, creating postural
asymmetries. For example, shortening of the psoas muscle on one side will lead to
lengthening of the psoas on the contralateral side.
- Shortening of limb girdle muscles (e.g. pectoralis, gluteus) can create complex
imbalance patterns both across local flexor/extensor pairs, across sides, and diagonally
across the trunk (e.g. shortening of pectoralis major on one side causing lengthening of
extensor muscles in contralateral hip).
- The end result of these imbalances is that the shortened muscles restrict the range of
movement, and the lengthened muscles cannot function optimally in a lengthened position.
It is thought that resistance stretching 1) allows the shortened muscles to lengthen and the
lengthened muscles to shorten by remodeling intramuscular and perimuscular connective tissue,
2) allows lengthened muscles to contract at a more favorable length and 3) allows for an
increase in flexion, extension, and flexibility through joint ranges of motion.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Terminated |
NCT04410523 -
Study of Efficacy and Safety of CSJ117 in Patients With Severe Uncontrolled Asthma
|
Phase 2 | |
| Completed |
NCT04624425 -
Additional Effects of Segmental Breathing In Asthma
|
N/A | |
| Active, not recruiting |
NCT03927820 -
A Pharmacist-Led Intervention to Increase Inhaler Access and Reduce Hospital Readmissions (PILLAR)
|
N/A | |
| Completed |
NCT04617015 -
Defining and Treating Depression-related Asthma
|
Early Phase 1 | |
| Recruiting |
NCT03694158 -
Investigating Dupilumab's Effect in Asthma by Genotype
|
Phase 4 | |
| Terminated |
NCT04946318 -
Study of Safety of CSJ117 in Participants With Moderate to Severe Uncontrolled Asthma
|
Phase 2 | |
| Completed |
NCT04450108 -
Vivatmo Pro™ for Fractional Exhaled Nitric Oxide (FeNO) Monitoring in U.S. Asthmatic Patients
|
N/A | |
| Completed |
NCT03086460 -
A Dose Ranging Study With CHF 1531 in Subjects With Asthma (FLASH)
|
Phase 2 | |
| Completed |
NCT01160224 -
Oral GW766944 (Oral CCR3 Antagonist)
|
Phase 2 | |
| Completed |
NCT03186209 -
Efficacy and Safety Study of Benralizumab in Patients With Uncontrolled Asthma on Medium to High Dose Inhaled Corticosteroid Plus LABA (MIRACLE)
|
Phase 3 | |
| Completed |
NCT02502734 -
Effect of Inhaled Fluticasone Furoate on Short-term Growth in Paediatric Subjects With Asthma
|
Phase 3 | |
| Completed |
NCT01715844 -
L-Citrulline Supplementation Pilot Study for Overweight Late Onset Asthmatics
|
Phase 1 | |
| Terminated |
NCT04993443 -
First-In-Human Study to Evaluate the Safety, Tolerability, Immunogenicity, and Pharmacokinetics of LQ036
|
Phase 1 | |
| Completed |
NCT02787863 -
Clinical and Immunological Efficiency of Bacterial Vaccines at Adult Patients With Bronchopulmonary Pathology
|
Phase 4 | |
| Recruiting |
NCT06033833 -
Long-term Safety and Efficacy Evaluation of Subcutaneous Amlitelimab in Adult Participants With Moderate-to-severe Asthma Who Completed Treatment Period of Previous Amlitelimab Asthma Clinical Study
|
Phase 2 | |
| Completed |
NCT03257995 -
Pharmacodynamics, Safety, Tolerability, and Pharmacokinetics of Two Orally Inhaled Indacaterol Salts in Adult Subjects With Asthma.
|
Phase 2 | |
| Completed |
NCT02212483 -
Clinical Effectiveness and Economical Impact of Medical Indoor Environment Counselors Visiting Homes of Asthma Patients
|
N/A | |
| Recruiting |
NCT04872309 -
MUlti-nuclear MR Imaging Investigation of Respiratory Disease-associated CHanges in Lung Physiology
|
||
| Withdrawn |
NCT01468805 -
Childhood Asthma Reduction Study
|
N/A | |
| Recruiting |
NCT05145894 -
Differentiation of Asthma/COPD Exacerbation and Stable State Using Automated Lung Sound Analysis With LungPass Device
|